Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications

Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tamoxifen therapy is successful for some patients, it does not provide adequate benefit for those who have estrogen receptor (ER)-negative cancers. Therefore, we approached novel treatment strategies by...

Descripción completa

Detalles Bibliográficos
Autores principales: Meeran, Syed M., Patel, Shweta N., Li, Yuanyuan, Shukla, Samriddhi, Tollefsbol, Trygve O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360625/
https://www.ncbi.nlm.nih.gov/pubmed/22662208
http://dx.doi.org/10.1371/journal.pone.0037748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360625/
https://www.ncbi.nlm.nih.gov/pubmed/22662208
http://dx.doi.org/10.1371/journal.pone.0037748

Ejemplares similares